(NASDAQ:AIRS) is a prominent player in the body contouring industry, offering premium procedures that cater to a growing market. On April 2, 2026, AIRS reported earnings per share (EPS) of $0.018, exceeding the estimated $0.01. However, the company's revenue of $33.44 million fell short of the anticipated $34.50 million.
Despite the revenue miss, AIRS showed a sequential improvement in same-store sales during the fourth quarter of 2025, compared to the first nine months of the year. This improvement is a result of strategic advancements made throughout 2025, as highlighted by CEO Yogi Jashnani. These advancements included enhancing business processes and implementing a new go-to-market strategy.
AIRS's financial results for the fourth quarter also revealed a net income of $1.28 million and a gross profit of $67.17 million. The EBITDA for the quarter was $2.07 million, indicating a positive trend compared to the previous year's period.
The company's cost of revenue was $33.72 million, contributing to a loss before tax of $2.49 million. Additionally, AIRS recorded an income tax expense of $3.77 million. Despite these challenges, the company's strategic efforts have led to increased financial flexibility, supporting future growth and market potential.
